Amneal Pharmaceuticals Inc - Ordinary Shares - Class A
AMRX
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.2B
Close$
$11.90
7.6% downside
Current Fair Value
7.6% downsideOvervalued by 7.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.20 Billion |
|---|---|
| Enterprise Value | $6.69 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.23 |
| Beta | 1.32 |
| Outstanding Shares | 328,933,000 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 35.4 |
|---|---|
| PEG | -15.45 |
| Price to Sales | 1.84 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.88 |
| Enterprise Value to EBIT | -66.84 |
| Enterprise Value to Net Income | 111 |
| Total Debt to Enterprise | 0.4 |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 7, 2026
EPS Estimate
$0.17
Average shareholder expectationRevenue Estimate
$719.66 M
Average shareholder expectationNext Earnings Call
Expected Date
August 4, 2026
EPS Estimate
$0.24
Average shareholder expectationRevenue Estimate
$754.29 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 2.2660▲ 222.58% |
|---|---|
| Total Calls | 50,000▼ 79.90% |
| Total Puts | 113,300▲ 1033.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 51.02%▲ 1.81% |
|---|---|
| Total Invested | $1.99B▲ 2.02% |
| Investors Holding | 317▲ 37.00% |
ESG Score
No data